Resume
Ana Catarina Gaspar do Nascimento completed the PhD in Veterinary Sciences in 2022/05/18 by Universidade de Lisboa Faculdade de Medicina Veterinária. Is Assistant Professor at Vasco da Gama University School.
Graus
-
Mestrado integradoMedicina Veterinária
-
DoutoramentoCiências Veterinárias
Publicações
Journal article
- 2023-01-06, TIM-3 Is a Potential Immune Checkpoint Target in Cats with Mammary Carcinoma, Cancers
- 2022-08-18, The Landscape of Tumor-Infiltrating Immune Cells in Feline Mammary Carcinoma: Pathological and Clinical Implications, Cells
- 2021-11-05, VISTA Is a Diagnostic Biomarker and Immunotherapy Target of Aggressive Feline Mammary Carcinoma Subtypes, Cancers
- 2021-05, Anaplastic Mammary Carcinoma in Cat, Veterinary Sciences
- 2021-04, HER2-Targeted Immunotherapy and Combined Protocols Showed Promising Antiproliferative Effects in Feline Mammary Carcinoma Cell-Based Models, Cancers
- 2021-03, Tyrosine Kinase Inhibitors Are Promising Therapeutic Tools for Cats with HER2-Positive Mammary Carcinoma, Pharmaceutics
- 2021-02-10, Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes, Frontiers in Veterinary Science
- 2021-01, Diagnostic Value of VEGF-A, VEGFR-1 and VEGFR-2 in Feline Mammary Carcinoma, Cancers
- 2021, Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model, Biochimica et Biophysica Acta - Reviews on Cancer
- 2020-05-28, Serum PD-1/PD-L1 Levels, Tumor Expression and PD-L1 Somatic Mutations in HER2-Positive and Triple Negative Normal-Like Feline Mammary Carcinoma Subtypes, Cancers
- 2020-03-02, Clinical Relevance of the serum CTLA-4 in Cats with Mammary Carcinoma, Scientific Reports
Conference abstract
- 2020-04-27, PD-1 and PD-L1 are diagnostic biomarkers and PD-L1 a promising therapeutic target in HER2-positive and triple negative normal-like feline mammary carcinoma subtypes
